Market Overview

Post Menopausal Osteoporosis - Pipeline Insight, 2018 -


The "Post
Menopausal Osteoporosis - Pipeline Insight, 2018"
pipelines has been added to's

This report offers a comprehensive insight of the pipeline (under
development) therapeutics scenario and growth prospects across Post
Menopausal Osteoporosis development.

The report provides detailed coverage of the pipeline landscape for this
mechanism of action, equipped with data from multiple sources with
complete pipeline analysis by developmental stage, associated
indications, route of administration and molecule type.

Pipeline Products covered across the following Developmental

  • Clinical
  • Non-clinical
  • Inactive: Discontinued and/or Dormant

Pipeline therapeutics development coverage provides descriptive product
profiles including (but not limited to) drug description, product
development and R&D activities encompassing clinical and pre-clinical
studies, designations, collaborations, licensing deals, grants,
technologies and patent details.

The report assesses the active Post Menopausal Osteoporosis pipeline
products by developmental stage, product type, molecule type, and
administration route.


  • The report provides a snapshot of the pipeline development for the
    Post Menopausal Osteoporosis
  • The report covers pipeline activity across the complete product
    development cycle i.e. clinical, pre-clinical and discovery stages for
    the Post Menopausal Osteoporosis
  • The report provides pipeline product profiles which includes product
    description, developmental activities, licensors & collaborators and
    chemical information
  • Provides pipeline assessment by monotherapy and combination therapy
    products, stage of development, route of administration, and molecule
    type for Post Menopausal Osteoporosis
  • The report also covers the dormant and discontinued pipeline projects
    related to the Post Menopausal Osteoporosis

Companies Featured

  • Amgen Inc
  • Enteris BioPharma Inc
  • Intas Pharmaceuticals Ltd
  • Ipsen SA
  • Ligand Pharmaceuticals Inc
  • Lupin Ltd
  • Oncobiologics Inc
  • Paras Biopharmaceuticals

Key Topics Covered

1. Report Introduction

2. Post Menopausal Osteoporosis Overview

3. Pipeline Therapeutics

4. Comparative Analysis

5. Products in Clinical Stage

6. Products in Pre-Clinical and Discovery Stage

7. Therapeutic Assessment

8. Inactive Products

For more information about this drug pipelines report visit

View Comments and Join the Discussion!